Cargando…

An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy

BACKGROUND: Cellulite is a serious cosmetic concern for most of the 90% of women affected by it. OBJECTIVE: To assess the clinical efficacy of a complex integral anti-cellulite gel. METHODS: This double-blind, randomized, placebo-controlled study involved 44 healthy women, aged 25–55 years. Subjects...

Descripción completa

Detalles Bibliográficos
Autores principales: Dupont, Eric, Journet, Michel, Oula, Marie-Laure, Gomez, Juan, Léveillé, Claude, Loing, Estelle, Bilodeau, Diane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933246/
https://www.ncbi.nlm.nih.gov/pubmed/24600240
http://dx.doi.org/10.2147/CCID.S53580
_version_ 1782304903711948800
author Dupont, Eric
Journet, Michel
Oula, Marie-Laure
Gomez, Juan
Léveillé, Claude
Loing, Estelle
Bilodeau, Diane
author_facet Dupont, Eric
Journet, Michel
Oula, Marie-Laure
Gomez, Juan
Léveillé, Claude
Loing, Estelle
Bilodeau, Diane
author_sort Dupont, Eric
collection PubMed
description BACKGROUND: Cellulite is a serious cosmetic concern for most of the 90% of women affected by it. OBJECTIVE: To assess the clinical efficacy of a complex integral anti-cellulite gel. METHODS: This double-blind, randomized, placebo-controlled study involved 44 healthy women, aged 25–55 years. Subjects had a normal to slightly overweight body mass index and presented slight to moderate cellulite on their thighs, buttocks, and/or hips at baseline. Subjects were randomly assigned to either the treated or placebo group and accordingly applied the active product or placebo on their hips, stomach, buttocks, and thighs, twice daily for 3 months. Skin tonicity, orange-peel aspect, and stubborn cellulite were assessed at day 0, 28, 56, and 84. A self-evaluation questionnaire was completed by all volunteers. RESULTS: At the end of the study, an average of 81% of the subjects applying the active product presented improvement in their cellulite condition versus 32% for the placebo group (all descriptors and sites combined). At day 84, skin tonicity, orange-peel appearance, and stubborn cellulite were improved in a significant manner (P<0.05) over placebo, on all studied areas. Skin tonicity improved on average by +41% for buttocks, +35% for hips, and +31% for thighs. Orange peel appearance was reduced on average by −25% for buttocks, −22% for hips, and −22% for thighs. Stubborn cellulite was reduced on average by −19% for buttocks, −24% for hips, and −22% for thighs. Circumference measurements decreased in a significant manner (P<0.05) over placebo, for the abdomen (average value of −1.1 cm) and thighs (average value of −0.8 cm). The product was well tolerated and perceived by the volunteers themselves as better performing than placebo on all criteria. CONCLUSION: All results validate the efficacy of the present integral formulation to significantly reduce signs of cellulite and reshape the silhouette.
format Online
Article
Text
id pubmed-3933246
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-39332462014-03-05 An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy Dupont, Eric Journet, Michel Oula, Marie-Laure Gomez, Juan Léveillé, Claude Loing, Estelle Bilodeau, Diane Clin Cosmet Investig Dermatol Original Research BACKGROUND: Cellulite is a serious cosmetic concern for most of the 90% of women affected by it. OBJECTIVE: To assess the clinical efficacy of a complex integral anti-cellulite gel. METHODS: This double-blind, randomized, placebo-controlled study involved 44 healthy women, aged 25–55 years. Subjects had a normal to slightly overweight body mass index and presented slight to moderate cellulite on their thighs, buttocks, and/or hips at baseline. Subjects were randomly assigned to either the treated or placebo group and accordingly applied the active product or placebo on their hips, stomach, buttocks, and thighs, twice daily for 3 months. Skin tonicity, orange-peel aspect, and stubborn cellulite were assessed at day 0, 28, 56, and 84. A self-evaluation questionnaire was completed by all volunteers. RESULTS: At the end of the study, an average of 81% of the subjects applying the active product presented improvement in their cellulite condition versus 32% for the placebo group (all descriptors and sites combined). At day 84, skin tonicity, orange-peel appearance, and stubborn cellulite were improved in a significant manner (P<0.05) over placebo, on all studied areas. Skin tonicity improved on average by +41% for buttocks, +35% for hips, and +31% for thighs. Orange peel appearance was reduced on average by −25% for buttocks, −22% for hips, and −22% for thighs. Stubborn cellulite was reduced on average by −19% for buttocks, −24% for hips, and −22% for thighs. Circumference measurements decreased in a significant manner (P<0.05) over placebo, for the abdomen (average value of −1.1 cm) and thighs (average value of −0.8 cm). The product was well tolerated and perceived by the volunteers themselves as better performing than placebo on all criteria. CONCLUSION: All results validate the efficacy of the present integral formulation to significantly reduce signs of cellulite and reshape the silhouette. Dove Medical Press 2014-02-20 /pmc/articles/PMC3933246/ /pubmed/24600240 http://dx.doi.org/10.2147/CCID.S53580 Text en © 2014 Dupont et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Dupont, Eric
Journet, Michel
Oula, Marie-Laure
Gomez, Juan
Léveillé, Claude
Loing, Estelle
Bilodeau, Diane
An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy
title An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy
title_full An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy
title_fullStr An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy
title_full_unstemmed An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy
title_short An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy
title_sort integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933246/
https://www.ncbi.nlm.nih.gov/pubmed/24600240
http://dx.doi.org/10.2147/CCID.S53580
work_keys_str_mv AT duponteric anintegraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT journetmichel anintegraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT oulamarielaure anintegraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT gomezjuan anintegraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT leveilleclaude anintegraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT loingestelle anintegraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT bilodeaudiane anintegraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT duponteric integraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT journetmichel integraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT oulamarielaure integraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT gomezjuan integraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT leveilleclaude integraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT loingestelle integraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy
AT bilodeaudiane integraltopicalgelforcellulitereductionresultsfromadoubleblindrandomizedplacebocontrolledevaluationofefficacy